Journal of the Neurological Sciences
Volume 283, Issue 1 , Pages 143-148 , 15 August 2009

Mitochondrial disorders, cognitive impairment and dementia

  • Josef Finsterer

      Affiliations

    • Corresponding Author InformationPostfach 20, 1180 Vienna, Austria. Tel.: +43 1 71165; fax: +43 1 4781711.
    • Reference: 5th International Congress on Vascular Dementia, Budapest, November 2007.

References 

  1. Zeviani M, Carelli V. Mitochondrial disorders. Curr Opin Neurol. 2007;20:564–571
  2. Kartsounis LD, Troung DD, Morgan-Hughes JA, Harding AE. The neuropsychological features of mitochondrial myopathies and encephalomyopathies. Arch Neurol. 1992;49:158–160
  3. Leonard JV, Schapira AHV. Mitochondrial respiratory chain disorders I: mitochondrial DNA defects. Lancet. 2000;355:299–304
  4. Schapira AHV. The “new” mitochondrial disorders. J Neurol Neurosurg Psychiatry. 2002;72:144–149
  5. Van Goethem G, Luoma P, Rantamaki M, Al Memar A, Kaakkola S, Hackman P, et al. POLG mutations in neurodegenerative disorders with ataxia but no muscle involvement. Neurology. 2004;63:1251–1257
  6. Dickerson BC, Holtzman D, Grant PE, Tian D. Case records of the Massachusetts General Hospital. Case 36-2005. A 61-year-old woman with seizure, disturbed gait, and altered mental status. N Engl J Med. 2005;353:2271–2280
  7. Bernier FP, Boneh A, Dennett X, Chow CW, Cleary MA, Thorburn DR. Diagnostic criteria for respiratory chain disorders in adults and children. Neurology. 2002;59:1406–1411
  8. Taylor RW, Schaefer AM, Barron MJ, McFarland R, Turnbull DM. The diagnosis of mitochondrial muscle disease. Neuromuscul Disord. 2004;14:237–245
  9. Walker UA, Collins S, Byrne E. Respiratory chain encephalomyopathies: a diagnsotic classification. Eur Neurol. 1996;36:260–267
  10. Wolf NI, Smeitink JAM. Mitochondrial disorders. A proposal for consensus diagnostic criteria in infants and children. Neurology. 2002;59:1402–1405
  11. Turconi AC, Benti R, Castelli E, Pochintesta S, Felisari G, Comi G, et al. Focal cognitive impairment in mitochondrial encephalomyopathies: a neuropsychological and neuroimaging study. J Neurol Sci. 1999;170:57–63
  12. Crimi M, Papadimitriou A, Galbiati S, Palamidou P, Fortunato F, Bordoni A, et al. A new mitochondrial DNA mutation in ND3 gene causing severe Leigh syndrome with early lethality. Pediatr Res. 2004;55:842–846
  13. Berio A, Piazzi A. A case of Kearns–Sayre syndrome with autoimmune thyroiditis and possible Hashimoto encephalopathy. Panminerva Med. 2002;44:265–269
  14. Koller H, Kornischka J, Neuen-Jacob E, Saleh A, von Giesen HJ, Schmiedel J, et al. Persistent organic personality change as rare psychiatric manifestation of MELAS syndrome. J Neurol. 2003;250:1501–1502
  15. Graf WD, Marin-Garcia J, Gao HG, Pizzo S, Naviaux RK, Markusic D, et al. Autism associated with the mitochondrial DNA G8363A transfer RNA(Lys) mutation. J Child Neurol. 2000;15:357–361
  16. Oliveira G, Diogo L, Grazina M, Garcia P, Ataide A, Marques C, et al. Mitochondrial dysfunction in autism spectrum disorders: a population-based study. Dev Med Child Neurol. 2005;47:185–189
  17. Jaksch M, Lochmuller H, Schmitt F, Volpel B, Obermaier-Kusser B, Horvath R. A mutation in mt tRNALeu(UUR) causing a neuropsychiatric syndrome with depression and cataract. Neurology. 2001;57:1930–1931
  18. Abe K, Yoshimura H, Tanaka H, Fujita N, Hikita T, Sakoda S. Comparison of conventional and diffusion-weighted MRI and proton MR spectroscopy in patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like events. Neuroradiology. 2004;46:113–117
  19. Finsterer J. Central nervous system manifestations of mitochondrial disorders. Acta Neurol Scand. 2006;114:217–238
  20. Finsterer J, Jarius C, Baumgartner M. Parkinson's disease associated with impaired oxidative phosphorylation. Neuroradiology. 2001;43:997–1000
  21. Finsterer J, Kopsa W. Basal ganglia calcification in mitochondrial disorders. Metab Brain Dis. 2005;20:219–226
  22. Bosbach S, Kornblum C, Schroder R, Wagner M. Executive and visuospatial deficits in patients with chronic progressive external ophthalmoplegia and Kearns–Sayre syndrome. Brain. 2003;126:1231–1240
  23. Molnár MJ, Valikovics A, Molnár S, Trón L, Diószeghy P, Mechler F, et al. Cerebral blood flow and glucose metabolism in mitochondrial disorders. Neurology. 2000;55:544–548
  24. Moller HE, Kurlemann G, Putzler M, Wiedermann D, Hilbich T, Fiedler B. Magnetic resonance spectroscopy in patients with MELAS. J Neurol Sci. 2005;229–230:131–139
  25. Grunwald F, Zierz S, Broich K, Schumacher S, Bockisch A, Biersack HJ. HMPAO-SPECT imaging resembling Alzheimer-type dementia in mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS). J Nucl Med. 1990;31:1740–1742
  26. Binder J, Hofmann S, Kreisel S, Wohrle JC, Bazner H, Krauss JK, et al. Clinical and molecular findings in a patient with a novel mutation in the deafness–dystonia peptide (DDP1) gene. Brain. 2003;126:1814–1820
  27. Kaufmann P, Shungu DC, Sano MC, Jhung S, Engelstad K, Mitsis E, et al. Cerebral lactic acidosis correlates with neurological impairment in MELAS. Neurology. 2004;62:1297–1302
  28. Sartor H, Loose R, Tucha O, Klein HE, Lange KW. MELAS: a neuropsychological and radiological follow-up study. Mitochondrial encephalomyopathy, lactic acidosis and stroke. Acta Neurol Scand. 2002;106:309–313
  29. Scaglia F, Northrop JL. The mitochondrial myopathy encephalopathy, lactic acidosis with stroke-like episodes (MELAS) syndrome: a review of treatment options. CNS Drugs. 2006;20:443–464
  30. Wang J, Markesbery WR, Lovell MA. Increased oxidative damage in nuclear and mitochondrial DNA in mild cognitive impairment. J Neurochem. 2006;96:825–832
  31. Montirosso R, Brambilla D, Felisari G, Sclaunich F, Filipponi E, Pozzoli U, et al. Electrophysiological analysis of cognitive slowing in subjects with mitochondrial encephalomyopathy. J Neurol Sci. 2002;194:3–9
  32. Dubeau F, De Stefano N, Zifkin BG, Arnold DL, Shoubridge EA. Oxidative phosphorylation defect in the brains of carriers of the tRNAleu(UUR) A3243G mutation in a MELAS pedigree. Ann Neurol. 2000;47:179–185
  33. Corona P, Lamantea E, Greco M, Carrara F, Agostino A, Guidetti D, et al. Novel heteroplasmic mtDNA mutation in a family with heterogeneous clinical presentations. Ann Neurol. 2002;51:118–122
  34. Morimoto N, Nagano I, Deguchi K, Morimoto N, Nagano I, Deguchi K, et al. Leber hereditary optic neuropathy with chorea and dementia resembling Huntington disease. Neurology. 2004;63:2451–2452
  35. Van Goethem G, Mercelis R, Lofgren , Van Goethem G, Mercelis R, Lofgren A, et al. Patient homozygous for a recessive POLG mutation presents with features of MERRF. Neurology. 2003;61:1811–1813
  36. Suzuki T, Koizumi J, Shiraishi H, Ofuku K, Sasaki M, Hori T, et al. Psychiatric disturbance in mitochondrial encephalomyopathy. J Neurol Neurosurg Psychiatry. 1989;52:920–922
  37. Lang CJ, Brenner P, Heuss D, Engelhardt A, Reichmann H, Seibel P, et al. Neuropsychological status of mitochondrial encephalomyopathies. Eur J Neurol. 1995;2:171–176
  38. Carod-Artal FJ, Herrero MD, Lara MC, Lopez-Gallardo E, Ruiz-Pesini E, Marti R, et al. Cognitive dysfunction and hypogonadotrophic hypogonadism in a Brazilian patient with mitochondrial neurogastrointestinal encephalomyopathy and a novel ECGF1 mutation. Eur J Neurol. 2007;14:581–585
  39. Valente L, Tiranti V, Marsano RM, Malfatti E, Fernandez-Vizarra E, Donnini C, et al. Infantile encephalopathy and defective mitochondrial DNA translation in patients with mutations of mitochondrial elongation factors EFG1 and EFTu. Am J Hum Genet. 2007;80:44–58
  40. Van Maldergem L, Trijbels F, DiMauro S, Sindelar PJ, Musumeci O, Janssen A, et al. Coenzyme Q-responsive Leigh's encephalopathy in two sisters. Ann Neurol. 2002;52:750–754
  41. Komura K, Nakano K, Ishigaki K, Tarashima M, Nakayama T, Sasaki K, et al. Creatine monohydrate therapy in a Leigh syndrome patient with A8344G mutation. Pediatr Int. 2006;48:409–412
  42. Tóth G, Morava E, Bene J, Selhorst JJ, Overmars H, Vreken P, et al. Carnitine-responsive carnitine insufficiency in a case of mtDNA 8993T>C mutation associated Leigh syndrome. J Inherit Metab Dis. 2001;24:421–422

PII: S0022-510X(09)00427-4

doi: 10.1016/j.jns.2009.02.347

Journal of the Neurological Sciences
Volume 283, Issue 1 , Pages 143-148 , 15 August 2009

Article Tools

* Image Usage & Resolution